{
    "root": "ef5e2b14-4bb2-4a9f-869e-502941445402",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "doxycycline hyclate",
    "value": "20250417",
    "ingredients": [
        {
            "name": "DOXYCYCLINE HYCLATE",
            "code": "19XTS3T51U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_34730"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "doxycycline hyclate tablet tetracycline class drugs indicated : rickettsial infections ( 1.1 ) sexually transmitted infections ( 1.2 ) respiratory tract infections ( 1.3 ) bacterial infections ( 1.4 ) ophthalmic infections ( 1.5 ) anthrax , including inhalational anthrax ( post-exposure ) ( 1.6 ) alternative treatment selected infections penicillin contraindicated ( 1.7 ) adjunctive therapy acute intestinal amebiasis severe acne ( 1.8 ) prophylaxis malaria ( 1.9 ) reduce development drug-resistant bacteria maintain effectiveness doxycycline hyclate tablets antibacterial drugs , doxycycline hyclate tablets used treat prevent infections proven strongly suspected caused bacteria . ( 1.10 )",
        "doid_entities": [
            {
                "text": "amebiasis (DOID:9181)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9181"
            },
            {
                "text": "acne (DOID:6543)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6543"
            },
            {
                "text": "malaria (DOID:12365)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12365"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute intestinal amebiasis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_2300"
            }
        ]
    },
    "contraindications": {
        "text": "\u25cf important instructions doxycycline hyclate tablets doxycycline hyclate tablets ( 150 mg ) broken two-thirds one-third provide 50 mg 100 mg strength , respectively . ( 2.1 ) \u25cf adults doxycycline hyclate tablets : usual 200 mg first day treatment ( administered 100 mg every 12 hours ) followed maintenance dose 100 mg daily . ( 2.1 ) management severe infections ( particularly chronic infections urinary tract ) , 100 mg every 12 hours recommended . ( 2.1 ) \u25cf pediatric patients doxycycline hyclate tablets : pediatric patients weighing less 45 kg severe life-threatening infections ( e.g . , anthrax , rocky mountain spotted fever ) , recommended dose 2.2 mg per kg body weight administered every 12 hours . pediatric patients weighing 45 kg receive adult dose . ( 2.3 ) pediatric patients less severe disease ( greater 8 years age weighing less 45 kg ) , recommended dose 4.4 mg per kg body weight divided two doses first day treatment , followed maintenance dose 2.2 mg per kg body weight ( given single daily dose divided two doses . pediatric patients weighing 45 kg , usual adult dose used . ( 2.3 ) full prescribing information additional indication information important instructions doxycycline hyclate tablets . ( 2.1 , 2.4 , 2.5 )",
        "doid_entities": [
            {
                "text": "rocky mountain spotted fever (DOID:0050052)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050052"
            },
            {
                "text": "spotted fever (DOID:11104)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11104"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic infections urinary",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_294422"
            }
        ]
    },
    "warningsAndPrecautions": "supplied doxycycline hyclate tablets usp , 75 mg light-teal , round , biconvex , film-coated tablets debossed `` lu `` one side `` c80 `` side . 75 mg tablet contains 86.6 mg doxycycline hyclate equivalent 75 mg doxycycline . bottles 30 tablets : ndc 68180-653-06 bottles 60 tablets : ndc 68180-653-07 bottles 90 tablets : ndc 68180-653-09 doxycycline hyclate tablets usp , 150 mg mossy-green , capsule-shaped , biconvex , film-coated tablets scored sides . side functionally scored tablet two parallel score line splitting 3 equal portions `` c `` debossed portion one side tablet , plain side . 150 mg tablet contains 173.2 mg doxycycline hyclate equivalent 150 mg doxycycline . bottles 30 tablets : ndc 68180-654-06 bottles 60 tablets : ndc 68180-654-07 bottles 90 tablets : ndc 68180-654-09 storage store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . protect light moisture . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "doxycycline hyclate contraindicated persons shown hypersensitivity tetracyclines . ( 4 )",
    "indications_original": "Doxycycline hyclate tablet is a tetracycline class drugs indicated for: Rickettsial infections ( 1.1 ) Sexually transmitted infections ( 1.2 ) Respiratory tract infections ( 1.3 ) Specific bacterial infections ( 1.4 ) Ophthalmic infections ( 1.5 ) Anthrax, including inhalational anthrax (post-exposure) ( 1.6 ) Alternative treatment for selected infections when      penicillin is contraindicated ( 1.7 ) Adjunctive therapy for acute intestinal amebiasis and      severe acne ( 1.8 ) Prophylaxis of malaria ( 1.9 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.10 )",
    "contraindications_original": "\u25cf Important Administration Instructions for Doxycycline Hyclate Tablets Doxycycline hyclate tablets (150 mg) can be broken into      two-thirds or one-third to provide a 50 mg and 100 mg strength,      respectively. ( 2.1 ) \u25cf Dosage in Adults for Doxycycline Hyclate Tablets : The usual dosage is 200 mg on the first day of treatment      (administered 100 mg every 12 hours) followed by a maintenance dose of 100      mg daily. ( 2.1 ) In the management of more severe infections (particularly      chronic infections of the urinary tract), 100 mg every 12 hours is      recommended. ( 2.1 ) \u25cf Dosage in Pediatric Patients for Doxycycline Hyclate Tablets : For all pediatric patients      weighing less than 45 kg with severe or life-threatening infections (e.g.,      anthrax, Rocky Mountain spotted fever), the recommended dose is 2.2 mg per      kg of body weight administered every 12 hours. Pediatric patients weighing      45 kg or more should receive the adult dose. ( 2.3 ) For pediatric patients with      less severe disease (greater than 8 years of age and weighing less than 45      kg), the recommended dose is 4.4 mg per kg of body weight divided into two      doses on the first day of treatment, followed by a maintenance dose of 2.2      mg per kg of body weight (given as a single daily dose or divided into two      doses. For pediatric patients weighing over 45 kg, the usual adult dose      should be used. (2.3) See Full Prescribing      Information for additional indication specific dosage information and      important administration instructions for doxycycline hyclate tablets. ( 2.1 , 2.4 , 2.5 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  Doxycycline Hyclate Tablets USP, 75 mg are light-teal, round, biconvex, film-coated tablets debossed with \"LU\" on one side and \"C80\" on the other side. Each 75 mg tablet contains 86.6 mg of doxycycline hyclate equivalent to 75 mg of doxycycline.\n                  Bottles of 30 tablets:\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68180-653-06\n                  Bottles of 60 tablets:\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68180-653-07\n                  Bottles of 90 tablets:\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68180-653-09\n                  Doxycycline Hyclate Tablets USP, 150 mg are mossy-green, capsule-shaped, biconvex, film-coated tablets scored on both sides. Each side of the functionally scored tablet has two parallel score line for splitting into 3 equal portions with \"C\" debossed on each portion of one side of the tablet, and plain on the other side. Each 150 mg tablet contains 173.2 mg of doxycycline hyclate equivalent to 150 mg of doxycycline.\n                  Bottles of 30 tablets:\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68180-654-06\n                  Bottles of 60 tablets:\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68180-654-07\n                  Bottles of 90 tablets:\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68180-654-09\n                  \n                     Storage\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Doxycycline hyclate is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines. ( 4 )",
    "drug": [
        {
            "name": "doxycycline hyclate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_34730"
        }
    ]
}